What is the generic name?

CERLIPONASE ALFA

What is the Trade Name for CERLIPONASE ALFA?

Brineura

What are the Indications for CERLIPONASE ALFA?

• 1 INDICATIONS AND USAGE Brineura is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. Brineura is a hydrolytic lysosomal N-terminal tripeptidyl peptidase indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. ( 1 )

References: https://open.fda.gov/